Not only does the winter season see a spike in joint issues, respiratory illnesses, urinary tract infections (UTIs), and skin ...

The winter season not only sees an increase in joint issues, respiratory illnesses, urinary tract infections ... abdominal ...

As winter begins, experts are witnessing a concerning trend which is a significant increase in kidney stone cases among adults aged 25-55 This seasonal spike in kidney stone formation has raised ...

The Food and Drug Administration (FDA) has approved Unloxcyt™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (mCSCC) or locally advanced CSCC (laCSCC) ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Larry Antonucci, M.D., MBA is the president & CEO of Lee Health, Southwest Florida’s major destination for health care ...

L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.